Galapagos NV ADR (GLPG)

Precedente Chiudi:

$28.45

Aprire:

$28.3

Volume 24 ore:

149.91K

Capitalizzazione di mercato:

$1.93B

Reddito:

$261.10M

Utile/perdita netta:

$228.29M

Rapporto P/E:

-12.52

EPS:

-2.3434

Flusso di cassa netto:

$-460.37M

1 W Prestazione:

+1.98%

1M Prestazione:

-9.67%

6M Prestazione:

-11.97%

1 anno Prestazione:

-26.48%

Intervallo 1D:

$28.30

$29.44

Portata 52W:

$28.30

$45.21

Galapagos NV ADR Stock (GLPG) Company Profile

Nome

Galapagos NV ADR

Settore

Healthcare (1189)

Industria

Biotechnology (685)

Telefono

32 1 534 29 00

Indirizzo

Generaal De Wittelaan L11 A3, Mechelen

Dipendente

712

Cinguettio

@GalapagosGlobal

Prossima data di guadagno

Ultimi documenti SEC

GLPG's Discussions on Twitter

Galapagos NV ADR Stock (GLPG) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-08-24	Downgrade	Citigroup	Buy → Neutral
2023-05-05	Aggiornamento	Raymond James	Mkt Perform → Outperform
2023-01-23	Aggiornamento	Jefferies	Underperform → Hold
2022-11-07	Downgrade	Raymond James	Outperform → Mkt Perform
2022-09-09	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2022-01-27	Aggiornamento	Citigroup	Neutral → Buy
2021-08-19	Downgrade	Barclays	Overweight → Equal Weight
2021-08-06	Downgrade	Deutsche Bank	Buy → Hold
2021-04-20	Iniziato	Deutsche Bank	Buy
2021-04-14	Aggiornamento	Barclays	Equal Weight → Overweight
2021-02-23	Aggiornamento	BofA Securities	Underperform → Neutral
2021-02-19	Aggiornamento	Raymond James	Mkt Perform → Outperform
2021-02-11	Downgrade	Citigroup	Buy → Neutral
2021-01-19	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2020-11-19	Iniziato	Maxim Group	Buy
2020-10-21	Downgrade	Goldman	Neutral → Sell
2020-08-25	Downgrade	Jefferies	Buy → Hold
2020-08-24	Downgrade	H.C. Wainwright	Buy → Neutral
2020-08-19	Downgrade	Barclays	Overweight → Equal Weight
2020-08-19	Aggiornamento	Citigroup	Neutral → Buy
2020-07-10	Downgrade	Stifel	Buy → Hold
2020-03-30	Aggiornamento	Jefferies	Hold → Buy
2020-03-18	Aggiornamento	RBC Capital Mkts	Underperform → Sector Perform
2020-02-25	Downgrade	Cantor Fitzgerald	Overweight → Neutral
2020-02-24	Downgrade	BofA/Merrill	Neutral → Underperform
2020-02-20	Downgrade	RBC Capital Mkts	Sector Perform → Underperform
2020-01-06	Downgrade	JP Morgan	Overweight → Neutral
2019-12-18	Downgrade	Citigroup	Buy → Neutral
2019-12-17	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2019-12-13	Downgrade	Credit Suisse	Outperform → Neutral
2019-12-02	Iniziato	BofA/Merrill	Neutral
2019-09-09	Ripresa	Morgan Stanley	Overweight
2019-07-31	Aggiornamento	UBS	Neutral → Buy
2019-07-29	Downgrade	Jefferies	Buy → Hold

Mostra tutto

Galapagos NV ADR Borsa (GLPG) Ultime notizie

Galapagos’ aandeelhouders keuren alle door de Raad van Bestuur voorgestelde besluiten goed op de jaarlijkse Gewone en Buitengewone Algemene Aandeelhoudersvergaderingen 2024

GlobeNewswire Inc.

Down -9.97% in 4 Weeks, Here's Why You Should You Buy the Dip in Galapagos (GLPG)

Zacks Investment Research

Bristol Myers (BMY) Reports Positive Colorectal Cancer Study Data

Zacks Investment Research

Fate Therapeutics (FATE) Surges 86.4% YTD on Pipeline Progress

Zacks Investment Research

Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024

GlobeNewswire Inc.

Amylyx (AMLX) Withdraws ALS Drug, Cuts Workforce by 70%

Zacks Investment Research

Galapagos NV ADR Azioni (GLPG) Dati Finanziari

Galapagos NV ADR (GLPG) Reddito 2024

Galapagos NV ADR (GLPG) Reddito netto 2024

Galapagos NV ADR (GLPG) Flusso di cassa 2024

Galapagos NV ADR (GLPG) Utile per azione 2024